Jiangxi Institute of Biological Products Inc. manufactures and exports biological products including Tetanus Antitoxin and Veterinary Medicine. The company offe...
Jiangxi Bioproducts rebounded 1.1% to close at HK$6.37 after a volatile session, recovering from an intraday low of HK$6.02 triggered by a profit warning yesterday. The stock initially fell 26% following the warning but rallied on approval of an animal health product, which offset concerns about its Hong Kong listing sustainability. Despite the bounce, the stock trades 40.7% below its 52-week high of HK$10.75 and well below its 20-day moving average of HK$7.483, with a year-to-date decline of 34.9%, though its PE of 18.7x and PB of 3.56x are moderate for the sector.
Weekly Recap | JIANGXI BIO -9.23%, consensus target above spot
Weekly Recap | JIANGXI BIO -10.63%, interim profit falls 60.99%
Weekly Recap | JIANGXI BIO +13.89%, consensus target above spot
Weekly Recap | JIANGXI BIO +10.57%, new coverage flags antiserum platform pivot